| Identification | Back Directory | [Name]
Cyclo(L-arginylglycyl-L-α-aspartyl-D-tyrosyl-L-cysteinyl) | [CAS]
1206475-79-7 | [Synonyms]
Cyclo(L-arginylglycyl-L-α-aspartyl-D-tyrosyl-L-cysteinyl) | [Molecular Formula]
C24H34N8O8S | [MOL File]
1206475-79-7.mol | [Molecular Weight]
594.64 |
| Chemical Properties | Back Directory | [density ]
1.60±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
4.01±0.10(Predicted) | [color ]
White to off-white | [Sequence]
cyclo(Arg-Gly-Asp-{d-Tyr}-Cys) |
| Hazard Information | Back Directory | [Uses]
Cyclo(RGDyC) is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo(RGDyC) can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer[1][2]. | [References]
[1] Lu Y, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013 Apr 5;24(13):135101. DOI:10.1088/0957-4484/24/13/135101
[2] Tang M, et al. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem. 2018 Jul 3;90(13):8188-8195. DOI:10.1021/acs.analchem.8b01580 |
|
| Company Name: |
YantaiBio Gold
|
| Tel: |
15083780366 |
| Website: |
|
|